• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾病负担估计的差异:源于不同的来源、定义和公式。

Disparities in chronic kidney disease burden estimates: From different sources, definitions, and equations.

作者信息

Ma Yao, Wang Xiang, Zhao Weihong

机构信息

Division of Nephrology, Department of Geriatrics, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, China.

Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.

出版信息

PLoS One. 2025 Aug 25;20(8):e0328653. doi: 10.1371/journal.pone.0328653. eCollection 2025.

DOI:10.1371/journal.pone.0328653
PMID:40853972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12377590/
Abstract

INTRODUCTION

The Global Burden of Disease (GBD) study provides updated epidemiological descriptions of chronic kidney disease (CKD), yet the discrepancies between its estimates and those from other sources remain unclear. Furthermore, attention is required due to the specificity of standard and computational tool for glomerular filtration rate (GFR). We aimed to evaluate CKD burden from various sources, definitions, and equations.

METHODS

This study analyzed CKD prevalence among US adults from 1999 to 2018, using data from the GBD study 2021 and the National Health and Nutrition Examination Survey (NHANES). We calculated average prevalence and estimated annual percentage change (EAPC) for the total population and by sex. The analysis was repeated using different definitions and equations. Additionally, a literature review was conducted to extend the comparison to a global scale.

RESULTS

Among US adults, the annual average estimates from the GBD and NHANES were similar, while long-term trends diverged, with disparities becoming more evident in sex-specific subgroups. Removal of racial coefficients led to an increase in the estimated CKD prevalence in Black individuals, while a decrease was observed in White individuals. The EKFC equation yielded the highest average and single-cycle CKD prevalence. Applying age-adapted thresholds reduced the prevalence of low estimated GFR (eGFR<threshold(s)) by approximately 50%, with numbers of older women reclassified into non-CKD categories.

CONCLUSIONS

This study highlights the differences in estimated CKD prevalence across various sources. Age-adjusted thresholds and the flexible EKFC equation hold promise for future applications in both epidemiological research and clinical practice.

摘要

引言

全球疾病负担(GBD)研究提供了慢性肾脏病(CKD)的最新流行病学描述,但其估计值与其他来源的估计值之间的差异仍不明确。此外,由于肾小球滤过率(GFR)标准和计算工具的特殊性,需要予以关注。我们旨在评估来自不同来源、定义和方程的CKD负担。

方法

本研究利用2021年GBD研究和美国国家健康与营养检查调查(NHANES)的数据,分析了1999年至2018年美国成年人中的CKD患病率。我们计算了总人口和按性别划分的平均患病率以及估计的年度百分比变化(EAPC)。使用不同的定义和方程重复进行分析。此外,还进行了文献综述,以将比较扩展到全球范围。

结果

在美国成年人中,GBD和NHANES的年度平均估计值相似,但长期趋势有所不同,在特定性别的亚组中差异变得更加明显。去除种族系数导致黑人个体的CKD估计患病率增加,而白人个体的患病率则下降。EKFC方程得出的平均和单周期CKD患病率最高。应用年龄适应性阈值可使低估计GFR(eGFR<阈值)的患病率降低约50%,许多老年女性被重新分类为非CKD类别。

结论

本研究强调了不同来源估计的CKD患病率之间的差异。年龄调整阈值和灵活的EKFC方程在未来的流行病学研究和临床实践中都有应用前景。

相似文献

1
Disparities in chronic kidney disease burden estimates: From different sources, definitions, and equations.慢性肾病负担估计的差异:源于不同的来源、定义和公式。
PLoS One. 2025 Aug 25;20(8):e0328653. doi: 10.1371/journal.pone.0328653. eCollection 2025.
2
Adoption of CKD-EPI (2021) for Glomerular Filtration Rate Estimation: Implications for UK Practice.采用CKD-EPI(2021)估算肾小球滤过率:对英国实践的影响。
Nephron. 2025;149(3):133-148. doi: 10.1159/000541689. Epub 2024 Sep 28.
3
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation.使用PREVENT方程对美国慢性肾脏病患者群体进行心血管疾病风险评估。
Am J Kidney Dis. 2025 Mar 5. doi: 10.1053/j.ajkd.2025.01.012.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.基于胱抑素C的估算肾小球滤过率的公式,不纳入种族和性别因素。
N Engl J Med. 2023 Jan 26;388(4):333-343. doi: 10.1056/NEJMoa2203769.
6
Evaluation of race-free eGFR equations in individuals of different ethnicity.不同种族个体中无种族因素的估算肾小球滤过率(eGFR)方程的评估。
Blood Press. 2025 Dec;34(1):2533456. doi: 10.1080/08037051.2025.2533456. Epub 2025 Jul 22.
7
Global trends of chronic kidney disease from 1990 to 2021: a systematic analysis for the global burden of disease study 2021.1990年至2021年慢性肾脏病的全球趋势:2021年全球疾病负担研究的系统分析
BMC Nephrol. 2025 Jul 14;26(1):385. doi: 10.1186/s12882-025-04309-7.
8
Global burden of chronic kidney disease due to hypertension (1990-2021): a systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study.1990 - 2021年高血压所致慢性肾脏病的全球负担:全球疾病负担研究(GBD)2021的流行病学趋势、危险因素及至2036年预测的系统分析
BMC Nephrol. 2025 Aug 9;26(1):448. doi: 10.1186/s12882-025-04386-8.
9
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.1990年至2023年全球、区域和国家接受替代治疗的肾衰竭及其相关病因的患病率:全球疾病负担研究2023的系统分析
Lancet Glob Health. 2025 Aug;13(8):e1378-e1395. doi: 10.1016/S2214-109X(25)00198-6.
10
Socioeconomic Status and Chronic Kidney Disease Among Black and White Adults: An Analysis of 2017-2020 NHANES.黑人和白人成年人的社会经济地位与慢性肾脏病:对2017 - 2020年美国国家健康与营养检查调查的分析
Kidney Med. 2025 Jun 16;7(8):101045. doi: 10.1016/j.xkme.2025.101045. eCollection 2025 Aug.

本文引用的文献

1
Discrepancies in neglected tropical diseases burden estimates in China: comparative study of real-world data and Global Burden of Disease 2021 data (2004-2020).中国被忽视热带病负担估计的差异:真实世界数据与《2021年全球疾病负担》数据(2004 - 2020年)的比较研究
BMJ. 2025 Feb 18;388:e080969. doi: 10.1136/bmj-2024-080969.
2
Global, regional, and national burden inequality of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年慢性肾脏病的全球、区域和国家负担不平等:全球疾病负担研究2021的系统分析
Front Med (Lausanne). 2025 Jan 15;11:1501175. doi: 10.3389/fmed.2024.1501175. eCollection 2024.
3
In Defense of Age-Based Estimated GFR Thresholds to Define CKD.
捍卫基于年龄的估计肾小球滤过率阈值以定义慢性肾脏病
Kidney Int Rep. 2024 Sep 28;10(1):1-3. doi: 10.1016/j.ekir.2024.09.018. eCollection 2025 Jan.
4
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
5
Discrepancies in dengue burden estimates: a comparative analysis of reported cases and global burden of disease study, 2010-2019.登革热负担估计的差异:2010-2019 年报告病例与全球疾病负担研究的比较分析。
J Travel Med. 2024 Jun 3;31(4). doi: 10.1093/jtm/taae069.
6
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
7
An update on the global disparities in kidney disease burden and care across world countries and regions.全球各国和地区肾脏疾病负担和护理的全球差异更新。
Lancet Glob Health. 2024 Mar;12(3):e382-e395. doi: 10.1016/S2214-109X(23)00570-3.
8
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset.澳大利亚初级医疗中慢性肾脏病的患病率:一项全国性全科医疗数据集分析
Kidney Int Rep. 2023 Nov 29;9(2):312-322. doi: 10.1016/j.ekir.2023.11.022. eCollection 2024 Feb.
9
Data mining of reference intervals for serum creatinine: an improvement in glomerular filtration rate estimating equations based on Q-values.血清肌酐参考区间的数据挖掘:基于 Q 值的肾小球滤过率估算方程的改进。
Clin Chem Lab Med. 2024 Jan 12;62(6):1138-1148. doi: 10.1515/cclm-2023-1421. Print 2024 May 27.
10
Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in United States cohorts.欧洲肾功能联盟(EKFC)基于肌酐的方程在美国队列中的表现。
Kidney Int. 2024 Mar;105(3):629-637. doi: 10.1016/j.kint.2023.11.024. Epub 2023 Dec 13.